Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$15,983,094
+$413,978 QoQ
Shares Held
62,933
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#853
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coastal Bridge Advisors, LLC holds $56,459,277 across 9 Drug Manufacturers - General names. JNJ ranks #1 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
62,933 | $15,983,094 | |
| 2 | ABBV |
AbbVie Inc.
|
61,434 | $15,459,251 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
68,834 | $8,696,487 | |
| 4 | AMGN |
Amgen Inc
|
14,287 | $5,173,608 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
56,768 | $3,270,972 | |
| 6 | LLY |
ELI LILLY & Co
|
2,467 | $2,958,994 | |
| 7 | MRK |
Merck & Co., Inc.
|
21,141 | $2,716,618 | |
| 8 | PFE |
Pfizer Inc
|
78,442 | $1,888,883 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,983,094 | 62,933 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $15,569,116 | 63,693 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,351,586 | 64,516 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,954,954 | 64,475 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $9,725,745 | 63,671 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,481,917 | 63,205 | Shares | Sole | 2025-08-25 | |
| 2024-12-31 | $2,481,968 | 17,162 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,876,240 | 17,748 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,542,891 | 17,398 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $2,739,059 | 17,315 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,707,840 | 17,276 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,684,507 | 17,236 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,919,607 | 17,639 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $2,907,645 | 18,759 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,211,850 | 18,182 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,931,005 | 17,942 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,194,824 | 17,998 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $3,165,150 | 17,859 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,050,178 | 17,830 | Shares | Sole | 2022-05-20 | |
| 2021-09-30 | $2,872,923 | 17,789 | Shares | Sole | 2022-05-20 | |
| 2021-06-30 | $3,056,421 | 18,553 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,656,553 | 16,164 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,259,662 | 14,358 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,352,601 | 15,802 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,278,487 | 16,202 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,088,900 | 15,930 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||